BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Hastings Center for Bioethics - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Hastings Center for Bioethics
X-ORIGINAL-URL:https://www.thehastingscenter.org
X-WR-CALDESC:Events for The Hastings Center for Bioethics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210712T100000
DTEND;TZID=America/New_York:20210712T100000
DTSTAMP:20260427T200832
CREATED:20210707T164056Z
LAST-MODIFIED:20210707T164103Z
UID:29549-1626084000-1626084000@www.thehastingscenter.org
SUMMARY:Breakthrough or Breakdown:  Should the FDA Have Approved the New Alzheimer’s Drug?
DESCRIPTION:Hastings Center President Mildred Z. Solomon will be hosting our next Hastings Conversations webinar as she will get to the bottom of the FDA’s decision and its consequences for patients and families\, the health care system\, and the integrity of regulatory oversight.
URL:https://www.thehastingscenter.org/hastings-center-event/breakthrough-or-breakdown-should-the-fda-have-approved-the-new-alzheimers-drug/
LOCATION:Online
CATEGORIES:Virtual Event
END:VEVENT
END:VCALENDAR